• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用可穿戴运动传感器对帕金森病患者的左旋多巴反应进行连续评估。

Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.

出版信息

IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164. doi: 10.1109/TBME.2017.2697764. Epub 2017 Apr 25.

DOI:10.1109/TBME.2017.2697764
PMID:28459677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5755593/
Abstract

OBJECTIVE

Fluctuations in response to levodopa in Parkinson's disease (PD) are difficult to treat as tools to monitor temporal patterns of symptoms are hampered by several challenges. The objective was to use wearable sensors to quantify the dose response of tremor, bradykinesia, and dyskinesia in individuals with PD.

METHODS

Thirteen individuals with PD and fluctuating motor benefit were instrumented with wrist and ankle motion sensors and recorded by video. Kinematic data were recorded as subjects completed a series of activities in a simulated home environment through transition from off to on medication. Subjects were evaluated using the unified Parkinson disease rating scale motor exam (UPDRS-III) at the start and end of data collection. Algorithms were applied to the kinematic data to score tremor, bradykinesia, and dyskinesia. A blinded clinician rated severity observed on video. Accuracy of algorithms was evaluated by comparing scores with clinician ratings using a receiver operating characteristic (ROC) analysis.

RESULTS

Algorithm scores for tremor, bradykinesia, and dyskinesia agreed with clinician ratings of video recordings (ROC area > 0.8). Summary metrics extracted from time intervals before and after taking medication provided quantitative measures of therapeutic response (p < 0.01). Radar charts provided intuitive visualization, with graphical features correlated with UPDRS-III scores (R = 0.81).

CONCLUSION

A system with wrist and ankle motion sensors can provide accurate measures of tremor, bradykinesia, and dyskinesia as patients complete routine activities.

SIGNIFICANCE

This technology could provide insight on motor fluctuations in the context of daily life to guide clinical management and aid in development of new therapies.

摘要

目的

帕金森病(PD)患者对左旋多巴的反应波动难以治疗,因为监测症状时间模式的工具受到多种挑战的阻碍。本研究旨在使用可穿戴传感器来量化个体 PD 震颤、运动迟缓及运动障碍的剂量反应。

方法

13 名伴有运动波动获益的 PD 患者佩戴腕部和踝部运动传感器,并通过视频进行记录。在模拟家庭环境中,通过从关药状态向服药状态过渡,让受试者完成一系列活动,同时记录运动学数据。在数据采集开始和结束时,受试者使用统一帕金森病评定量表运动部分(UPDRS-III)进行评估。应用算法对运动学数据进行评分,以评估震颤、运动迟缓及运动障碍。一位盲法临床医生对视频记录中的严重程度进行评分。通过受试者工作特征(ROC)分析,将算法评分与临床医生的评分进行比较,以评估算法的准确性。

结果

震颤、运动迟缓及运动障碍的算法评分与视频记录的临床医生评分一致(ROC 曲线下面积>0.8)。服药前后时间间隔提取的综合指标提供了治疗反应的定量测量(p<0.01)。雷达图提供了直观的可视化效果,图形特征与 UPDRS-III 评分相关(R=0.81)。

结论

腕部和踝部运动传感器系统可以在患者完成日常活动时提供准确的震颤、运动迟缓及运动障碍评估。

意义

该技术可在日常生活背景下提供对运动波动的深入了解,以指导临床管理并有助于新疗法的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/f73de4dd7cab/nihms930020f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/48294f1436a0/nihms930020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/632c918b4bb8/nihms930020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/a82afa568c32/nihms930020f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/f73de4dd7cab/nihms930020f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/48294f1436a0/nihms930020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/632c918b4bb8/nihms930020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/a82afa568c32/nihms930020f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983e/5755593/f73de4dd7cab/nihms930020f4.jpg

相似文献

1
Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.使用可穿戴运动传感器对帕金森病患者的左旋多巴反应进行连续评估。
IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164. doi: 10.1109/TBME.2017.2697764. Epub 2017 Apr 25.
2
A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson's disease using an ambulatory monitor.使用动态监测仪测量帕金森病患者的运动迟缓与运动障碍时间的方法。
J Neuroeng Rehabil. 2021 Jul 16;18(1):116. doi: 10.1186/s12984-021-00905-4.
3
A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States.可穿戴传感器用于量化帕金森病运动状态的治疗反应指数。
IEEE J Biomed Health Inform. 2018 Sep;22(5):1341-1349. doi: 10.1109/JBHI.2017.2777926. Epub 2017 Nov 27.
4
Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease.客观运动传感器评估与帕金森病中全局左旋多巴诱导运动障碍的评分高度相关。
J Parkinsons Dis. 2013 Jan 1;3(3):399-407. doi: 10.3233/JPD-120166.
5
Using Wearable Technology to Generate Objective Parkinson's Disease Dyskinesia Severity Score: Possibilities for Home Monitoring.利用可穿戴技术生成客观的帕金森病运动障碍严重程度评分:家庭监测的可能性。
IEEE Trans Neural Syst Rehabil Eng. 2017 Oct;25(10):1853-1863. doi: 10.1109/TNSRE.2017.2690578. Epub 2017 Apr 3.
6
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.帕金森病丘脑底核刺激的十年随访结果:一项盲法评估。
Arch Neurol. 2011 Dec;68(12):1550-6. doi: 10.1001/archneurol.2011.182. Epub 2011 Aug 8.
7
Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge.基于运动传感器的腿部敏捷测试中帕金森病运动症状评估:左旋多巴挑战的结果。
IEEE J Biomed Health Inform. 2020 Jan;24(1):111-119. doi: 10.1109/JBHI.2019.2898332. Epub 2019 Feb 8.
8
The patient's perspective: The effect of levodopa on Parkinson symptoms.患者视角:左旋多巴对帕金森症状的影响。
Parkinsonism Relat Disord. 2017 Feb;35:48-54. doi: 10.1016/j.parkreldis.2016.11.015. Epub 2016 Nov 27.
9
Motion sensor dyskinesia assessment during activities of daily living.日常活动中运动传感器运动障碍的评估。
J Parkinsons Dis. 2014;4(4):609-15. doi: 10.3233/JPD-140348.
10
Differential progression of motor impairment in levodopa-treated Parkinson's disease.左旋多巴治疗帕金森病中运动障碍的差异进展
Mov Disord. 2000 May;15(3):479-84. doi: 10.1002/1531-8257(200005)15:3<479::AID-MDS1009>3.0.CO;2-P.

引用本文的文献

1
Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial.与其他方法相比,基于可穿戴设备信息进行帕金森病药物调整:随机临床试验
NPJ Parkinsons Dis. 2025 Aug 20;11(1):249. doi: 10.1038/s41531-025-00977-2.
2
Estimating motor symptom presence and severity in Parkinson's disease from wrist accelerometer time series using ROCKET and InceptionTime.使用ROCKET和InceptionTime从腕部加速度计时间序列估计帕金森病患者运动症状的存在和严重程度。
Sci Rep. 2025 May 31;15(1):19140. doi: 10.1038/s41598-025-04263-2.
3
Personalized medication recommendations for Parkinson's disease patients using gated recurrent units and SHAP interpretability.

本文引用的文献

1
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.帕金森病及其管理:第1部分:疾病实体、危险因素、病理生理学、临床表现及诊断。
P T. 2015 Aug;40(8):504-32.
2
Body-Worn Sensors in Parkinson's Disease: Evaluating Their Acceptability to Patients.帕金森病中的可穿戴传感器:评估患者对其的接受度。
Telemed J E Health. 2016 Jan;22(1):63-9. doi: 10.1089/tmj.2015.0026. Epub 2015 Jul 17.
3
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease.
使用门控循环单元和SHAP可解释性为帕金森病患者提供个性化药物推荐。
Sci Rep. 2025 May 30;15(1):19074. doi: 10.1038/s41598-025-04217-8.
4
Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease.帕金森病中运动功能临床测量与动态心电图监测仪的比较。
Clin Park Relat Disord. 2025 Apr 17;12:100325. doi: 10.1016/j.prdoa.2025.100325. eCollection 2025.
5
Dual stream transformer for medication state classification in Parkinson's disease patients using facial videos.用于帕金森病患者药物状态分类的双流变压器,使用面部视频。
NPJ Digit Med. 2025 Apr 26;8(1):226. doi: 10.1038/s41746-025-01630-1.
6
Commercial symptom monitoring devices in Parkinson's disease: benefits, limitations, and trends.帕金森病的商业症状监测设备:益处、局限性及趋势
Front Neurol. 2024 Dec 23;15:1470928. doi: 10.3389/fneur.2024.1470928. eCollection 2024.
7
Biochemical Sensors for Personalized Therapy in Parkinson's Disease: Where We Stand.用于帕金森病个性化治疗的生化传感器:我们的现状
J Clin Med. 2024 Dec 7;13(23):7458. doi: 10.3390/jcm13237458.
8
Development of a remote therapeutic monitoring platform: applications for movement disorders.远程治疗监测平台的开发:运动障碍的应用
Sci Rep. 2024 Dec 1;14(1):29837. doi: 10.1038/s41598-024-80567-z.
9
[Commercial devices for monitoring symptoms in Parkinson's disease: benefits, limitations and trends].[用于监测帕金森病症状的商用设备:益处、局限性及趋势]
Rev Neurol. 2024 Oct 16;79(8):229-237. doi: 10.33588/rn.7908.2024253.
10
Multi-Shared-Task Self-Supervised CNN-LSTM for Monitoring Free-Body Movement UPDRS-III Using Wearable Sensors.用于使用可穿戴传感器监测自由身体运动UPDRS-III的多共享任务自监督卷积神经网络-长短期记忆网络
Bioengineering (Basel). 2024 Jul 7;11(7):689. doi: 10.3390/bioengineering11070689.
通过单一传感器检测和监测帕金森病患者的运动障碍。
Mov Disord. 2015 Aug;30(9):1267-71. doi: 10.1002/mds.26313. Epub 2015 Jul 14.
4
Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study.帕金森症状的定量居家评估:SENSE-PARK可行性与可用性研究。
BMC Neurol. 2015 Jun 10;15:89. doi: 10.1186/s12883-015-0343-z.
5
An objective fluctuation score for Parkinson's disease.帕金森病的客观波动评分
PLoS One. 2015 Apr 30;10(4):e0124522. doi: 10.1371/journal.pone.0124522. eCollection 2015.
6
Motion sensor dyskinesia assessment during activities of daily living.日常活动中运动传感器运动障碍的评估。
J Parkinsons Dis. 2014;4(4):609-15. doi: 10.3233/JPD-140348.
7
Automatic and objective assessment of alternating tapping performance in Parkinson's disease.帕金森病患者交替叩击动作的自动和客观评估。
Sensors (Basel). 2013 Dec 9;13(12):16965-84. doi: 10.3390/s131216965.
8
Continuous in-home monitoring of essential tremor.持续性居家震颤监测。
Parkinsonism Relat Disord. 2014 Jan;20(1):37-40. doi: 10.1016/j.parkreldis.2013.09.009. Epub 2013 Sep 19.
9
Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease.客观运动传感器评估与帕金森病中全局左旋多巴诱导运动障碍的评分高度相关。
J Parkinsons Dis. 2013 Jan 1;3(3):399-407. doi: 10.3233/JPD-120166.
10
Automated assessment of bradykinesia and dyskinesia in Parkinson's disease.帕金森病运动迟缓与运动障碍的自动化评估。
J Parkinsons Dis. 2012;2(1):47-55. doi: 10.3233/JPD-2012-11071.